294 related articles for article (PubMed ID: 12114351)
1. Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma.
Dempsey OJ; Fowler SJ; Wilson A; Kennedy G; Lipworth BJ
Chest; 2002 Jul; 122(1):151-9. PubMed ID: 12114351
[TBL] [Abstract][Full Text] [Related]
2. Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.
Lipworth BJ; Dempsey OJ; Aziz I; Wilson AM
Am J Med; 2000 Aug; 109(2):114-21. PubMed ID: 10967152
[TBL] [Abstract][Full Text] [Related]
3. Initial improvements in lung function and bronchial hyperresponsiveness are maintained during 5 years of treatment with inhaled beclomethasone dipropionate and terbutaline.
Douma WR; Kerstjens HA; de Gooijer A; Overbeek SE; Koëter GH; Postma DS;
Chest; 2002 Jan; 121(1):151-7. PubMed ID: 11796444
[TBL] [Abstract][Full Text] [Related]
4. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma.
Ukena D; Harnest U; Sakalauskas R; Magyar P; Vetter N; Steffen H; Leichtl S; Rathgeb F; Keller A; Steinijans VW
Eur Respir J; 1997 Dec; 10(12):2754-60. PubMed ID: 9493656
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene modifier vs inhaled corticosteroid in mild-to-moderate asthma: clinical and anti-inflammatory effects.
Perng DW; Huang HY; Lee YC; Perng RP
Chest; 2004 May; 125(5):1693-9. PubMed ID: 15136378
[TBL] [Abstract][Full Text] [Related]
6. Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma.
O'Connor BJ; Löfdahl CG; Balter M; Szczeklik A; Boulet LP; Cairns CB
Respir Med; 2007 Jun; 101(6):1088-96. PubMed ID: 17360171
[TBL] [Abstract][Full Text] [Related]
7. Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.
Tamaoki J; Isono K; Taira M; Tagaya E; Nakata J; Kawatani K; Nagai A
Allergy Asthma Proc; 2008; 29(2):189-96. PubMed ID: 18430318
[TBL] [Abstract][Full Text] [Related]
8. A comparison of double-strength beclomethasone dipropionate (84 microg) MDI with beclomethasone dipropionate (42 microg) MDI in the treatment of asthma.
Nathan RA; Nolop KB; Cuss FM; Lorber RR
Chest; 1997 Jul; 112(1):34-9. PubMed ID: 9228354
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids.
Tsuchida T; Matsuse H; Machida I; Kondo Y; Saeki S; Tomari S; Obase Y; Matsuo N; Shimoda T; Kohno S
Allergy Asthma Proc; 2005; 26(4):287-91. PubMed ID: 16270722
[TBL] [Abstract][Full Text] [Related]
10. A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma.
Nathan RA; Bleecker ER; Kalberg C;
Am J Med; 2001 Aug; 111(3):195-202. PubMed ID: 11530030
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma.
Dempsey OJ; Kennedy G; Lipworth BJ
J Allergy Clin Immunol; 2002 Jan; 109(1):68-74. PubMed ID: 11799368
[TBL] [Abstract][Full Text] [Related]
12. Effects of 2 weeks of treatment with fluticasone propionate 100 mcg b.d. by comparison with zafirlukast 20 mg b.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma.
Westbroek J; Pasma HR
Respir Med; 2000 Feb; 94(2):112-8. PubMed ID: 10714415
[TBL] [Abstract][Full Text] [Related]
13. Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy.
Kim KT; Ginchansky EJ; Friedman BF; Srebro S; Pepsin PJ; Edwards L; Stanford RH; Rickard K
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):398-406. PubMed ID: 11101185
[TBL] [Abstract][Full Text] [Related]
14. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
Virchow JC; Prasse A; Naya I; Summerton L; Harris A
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090
[TBL] [Abstract][Full Text] [Related]
15. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma].
Ukena D; Harnest U; Sakalauskas R; Magyar P; Vetter N; Steffen H; Leichtl S; Rathgeb F; Keller A; Steinijans VW
Pneumologie; 1998 Jul; 52(7):377-84. PubMed ID: 9738388
[TBL] [Abstract][Full Text] [Related]
17. Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma.
Wang Y; Wang CZ; Lin KX; Qian GS; Zhuo WL; Li SP; Zhao ZQ; Liao XQ; Song YX
Respirology; 2005 Mar; 10(2):189-95. PubMed ID: 15823184
[TBL] [Abstract][Full Text] [Related]
18. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
Busse W; Wolfe J; Storms W; Srebro S; Edwards L; Johnson M; Bowers BW; Rogenes PR; Rickard K
J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
[TBL] [Abstract][Full Text] [Related]
19. Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma.
Yurdakul AS; Calişir HC; Tunçtan B; Ogretensoy M
Respir Med; 2002 May; 96(5):322-9. PubMed ID: 12113382
[TBL] [Abstract][Full Text] [Related]
20. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
Tomari S; Shimoda T; Kawano T; Mitsuta K; Obase Y; Fukushima C; Matsuse H; Kohno S
Ann Allergy Asthma Immunol; 2001 Aug; 87(2):156-61. PubMed ID: 11527250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
